恢复期血浆疗法

打印

研究

妙佑医疗国际研究人员正在探索 COVID-19 恢复期血浆疗法。他们主要关注因 COVID-19 住院的患者以及因 COVID-19 导致免疫系统显著受损的患者。

研究目标旨在确定 COVID-19 恢复期血浆疗法能否提高重症患者的康复机会。研究人员也将测试 COVID-19 恢复期血浆疗法能否帮助中度患者避免病情恶化。研究人员还将针对 COVID-19 恢复期血浆疗法进行测试，确定是否可以避免住院治疗。

了解更多关于妙佑医疗国际 COVID-19 研究的信息。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在恢复期血浆治疗领域的文献著述列表。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

关于在 Mayo Clinic 治疗
Dec. 30, 2025
打印
  1. Investigational COVID-19 convalescent plasma. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma. Accessed March 24, 2025.
  2. Hoffman R, et al. Principles of plasma and plasma derivatives. In: Hematology. 8th edition. Elsevier. 2023. https://www.clinicalkey.com. Accessed March 24, 2025.
  3. Marano G, et al. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016; doi:10.2450/2015.0131-15.
  4. Emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed March 24, 2025.
  5. AskMayoExpert. COVID-19: Outpatient management. Convalescent Plasma. Mayo Clinic; 2025.
  6. Rajendran K, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Journal of Medical Virology. 2020; doi:10.1002/jmv.25961.
  7. Senefeld JW, et al. COVID-19 Convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. Journal of the American Medical Association: Network Open. 2023; doi:10.1001/jamanetworkopen.2022.50647.
  8. COVID-19 treatments and medications. Centers for Disease Control and Prevention. https://www.cdc.gov/covid/treatment/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html#cdc_treatment_overview-covid-19-treatment-options. Accessed March 24, 2025.
  9. Kim AY et al. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. https://www.uptodate.com/contents/search. Accessed March 24, 2025.
  10. Infectious disease, HLA and ABO donor qualification testing. American Red Cross. https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html. Accessed March 24, 2025.
  11. Medical review (expert opinion). Mayo Clinic. March 24, 2025.
  12. Whole Blood and blood components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived) and Apheresis Convalescent Plasma, High Titer, Anti-SARS-CoV-2). https://www.fda.gov/vaccines-blood-biologics/whole-blood-and-blood-components-convalescent-plasma-high-titer-anti-sars-cov-2-whole-blood-derived. Accessed April 4, 2025.
  13. Dragotakes Q, et al. Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proceedings of the National Academy of Sciences of the United States of America. 2024; doi:10.1073/pnas.2414957121.

相关

产品与服务

恢复期血浆疗法